Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) — AI analysis & news
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) stock: 4 recent news items, negative aggregate sentiment, AI analysis and market context on BestAIBroker.
Current sentiment read
Across the last 4 indexed SUPN stories, aggregate finance-aware sentiment is negative (-0.65 on a -1 to +1 scale).
Latest SUPN news
- Supernus Pharmaceuticals stock hits 52-week low at 40.5 USD By Investing.com - Investing.com India · Investing.com India
- Supernus Pharmaceuticals stock hits 52-week low at 40.5 USD By Investing.com - Investing.com UK · Investing.com UK
- Supernus Pharmaceuticals stock hits 52-week low at 42.39 USD By Investing.com - Investing.com India · Investing.com India
- Supernus Pharmaceuticals stock hits 52-week low at 42.39 USD By Investing.com - Investing.com UK · Investing.com UK
FAQ
What is the current sentiment for SUPN stock?
Aggregate finance-aware sentiment across the last 4 indexed SUPN news stories is negative (-0.65 on a -1 to +1 scale).